Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Feb 2:4:21-6.
doi: 10.2147/opth.s8409.

Trimetazidine for prevention of induced ischemia and reperfusion of guinea pig retina

Affiliations

Trimetazidine for prevention of induced ischemia and reperfusion of guinea pig retina

T Demir et al. Clin Ophthalmol. .

Abstract

Objective: Trimetazidine (TMZ) has been used to protect against ischemia/reperfusion (I/R) injury of many tissues. We aimed to evaluate the effect of TMZ during retinal I/R in a guinea pig model.

Study design/patients and methods: An experimental study in retinal I/R. Three groups of five guinea pigs were studied to include a control, placebo, and drug test groups. Prior to the application of 90 minutes of high intraocular pressure (IOP) to induce retinal ischemia followed by 24 hours of reperfusion, we applied intraperitoneal saline to the placebo group and 3 mg/kg of TMZ for the drug test group and repeated the injections at intervals of six hours for four cycles. Both eyes of the animals were enucleated at the end of the reperfusion period. Biochemical assay and histopathologic evaluation was performed on one randomly selected eye of each animal. The level of retinal-free malondialdehyde (MDA) and retinal layer thicknesses were determined and comparisons were then made with the control group.

Results: The mean free MDA level increased in the placebo group (P = 0.006) but not in the drug group (P > 0.05). We observed polymorphonucleated leukocyte infiltration, retinal edema and hydropic degeneration in the retina of the placebo group. However, significant histopathologic change was not observed in specimens of the drug group.

Conclusions: This study suggests TMZ has a beneficial effect on retinal lipid peroxidation and histopathologic changes due to I/R injury.

Keywords: ischemia/reperfusion; retina; trimetazidine.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The graphical changes of thickness of the retinal layers. Abbreviations: GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer; PL, photoreceptor layer.
Figure 2
Figure 2
Placebo: Microphotograph of degeneration of retinal ganglion cells (broken arrow), edema of inner plexiform layer (long arrow), pyknotic cells in inner nuclear layer (short arrow) and polymorphonuclear leukocytes (thick arrow). Notes: Hematoxylin and eosin 400 × magnification.
Figure 3
Figure 3
Drug: Histological photograph of hydropic degeneration of a few ganglion cells (broken arrow), slight edema of inner plexiform layer (long arrow), and hydropic degeneration of a few cells in inner nuclear layer (short arrow). Notes: Hematoxylin and eosin 400 × magnification.

Similar articles

Cited by

References

    1. Sellier P, Audoin P, Rayen B, et al. Acute effects of trimetazidine evaluated by exercise testing. Eur J Clin Pharmacol. 1987;33:205–207. - PubMed
    1. Maupoil V, Rochette L, Tabard A, Clauser P, Harpey C. Evolution of free radical formation during low-flow ischemia and reperfusion in isolated rat heart. Cardiovasc Drug Ther. 1990;4:791–796. - PubMed
    1. Fantini E, Demaison L, Sentex E, Grynberg A, Athias P. Some biochemical aspects of the pprotective effect of trimetazidine on rat cardiomyocytes during hypoxia and reoxygenation. J Mol Cell Cardiol. 1994;26:949–958. - PubMed
    1. Fitoussi M, Rochette L, Brlet J. Incidences fonctionnelles et metaboliues d’un pretraitement par la trimetazidine u niveau du coeur de rat. Arch Mal Coeur et Visseux. 1985;78:460–465.
    1. Harpey C, Clauser P, Labrid C, Freyria JL, Poririer J. Trimetazidine, a cellular anti-ischemic agent. Cardiovasc Drug Rev. 1989;4:292–312.